Key facts
- This page summarizes Jacqueline Kunzler's Form 4 filing for BAXTER INTERNATIONAL INC (BAX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Mar 2023, 15:07.
Jacqueline Kunzler - 01 Mar 2023 Form 4 Insider Report for BAXTER INTERNATIONAL INC (BAX)
- Reporting relationship
- SVP, Chief Quality Officer
- Issuer ticker
- BAX
- Reported as of
- 01 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2023, 15:07:17 UTC
- Prior SEC filing
- 23 Feb 2023
- Next SEC filing
- 06 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew Rice, as attorney in-fact for Jacqueline Kunzler
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jacqueline Kunzler filed Form 4 for BAXTER INTERNATIONAL INC (BAX) on 03 Mar 2023.
Change
- Previous filing in this sequence was filed on 23 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BAX
transaction
Common Stock, $1 par value
Award
- Transaction value
- $0
- Shares
- +6,171
- Change %
- +37%
- Price
- $0.000000
- Shares after
- 22,896
- Date
- 01 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BAX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +25,586
- Change %
- Price
- $0.000000
- Shares after
- 25,586
- Date
- 01 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock, $1 par value
- Underlying amount
- 25,586
- Exercise price
- $39.06
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.
Footnote F2
The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date.